These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21206182)

  • 1. Posttransplant lymphoproliferative disorders of the central nervous system after kidney transplantation: single center experience over 40 years. Two case reports.
    Arita H; Izumoto S; Kinoshita M; Okita Y; Hashimoto N; Fujita T; Ichimaru N; Takahara S; Yoshimine T
    Neurol Med Chir (Tokyo); 2010; 50(12):1079-83. PubMed ID: 21206182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of monomorphic primary central nervous system post-transplantation lymphoproliferative disorder 5 years after kidney transplantation.
    Yaginuma T; Yamamoto H; Mitome J; Tanno Y; Yamamoto I; Kobayashi A; Mafune A; Hayakawa H; Yokoyama K; Mori R; Ohashi H; Kaito N; Joki T; Miki J; Yamada H; Furuta N; Matsushima S; Fukuda T; Hosoya T
    Transpl Infect Dis; 2012 Oct; 14(5):E102-6. PubMed ID: 22931101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage.
    Crane GM; Powell H; Kostadinov R; Rocafort PT; Rifkin DE; Burger PC; Ambinder RF; Swinnen LJ; Borowitz MJ; Duffield AS
    Oncotarget; 2015 Oct; 6(32):33849-66. PubMed ID: 26460822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nervous system lymphoproliferative disorder in pediatric kidney transplant recipients.
    Traum AZ; Rodig NM; Pilichowska ME; Somers MJ
    Pediatr Transplant; 2006 Jun; 10(4):505-12. PubMed ID: 16712612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttransplant lymphoproliferative disorders in kidney transplant recipients: an Iranian multicenter experience.
    Einollahi B; Lessan-Pezeshki M; Nourbala MH; Simforoosh N; Pourfarziani V; Nemati E; Nafar M; Basiri A; Pour-Reza-Gholi F; Firoozan A; Ghadiani MH; Makhdoomi K; Ghafari A; Ahmadpour P; Oliaei F; Ardalan MR; Makhlough A; Samimagham HR; Azmandian J; Razeghi E; Shahbazian H
    Iran J Kidney Dis; 2008 Oct; 2(4):227-33. PubMed ID: 19377242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttransplant lymphoproliferative disorder among renal transplant patients in relation to the use of mycophenolate mofetil.
    Funch DP; Ko HH; Travasso J; Brady J; Kew CE; Nalesnik MA; Walker AM
    Transplantation; 2005 Nov; 80(9):1174-80. PubMed ID: 16314782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Remission induced by dose-reduction of immunosuppressants alone in a patient with post-transplant lymphoproliferative disorder of central nervous system origin].
    Minauchi K; Koizumi K; Kondo M; Takigami M; Harada H; Fujita H; Mukai M
    Rinsho Ketsueki; 2011 May; 52(5):272-7. PubMed ID: 21646772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry.
    Zimmermann H; Nitsche M; Pott C; Reinke P; Babel N; Hermann RM; Hauser IA; Hahn D; Ritgen M; Pietschmann C; Klapper W; Anagnostopoulos I; Trappe RU;
    Ann Hematol; 2021 Aug; 100(8):2043-2050. PubMed ID: 33973053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transplantation lymphoproliferative disorders (PTLD) localized in the central nervous system: report from an international survey on PTLD.
    Khedmat H; Taheri S
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):235-42. PubMed ID: 23538344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of central nervous system posttransplant lymphoproliferative disorders: lessons from pediatric autopsies.
    Gheorghe G; Radu O; Milanovich S; Hamilton RL; Jaffe R; Southern JF; Ozolek JA
    Pediatr Dev Pathol; 2013; 16(2):67-73. PubMed ID: 23286282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Central Nervous System Hodgkin Lymphoma-Like Posttransplant Lymphoproliferative Disorder.
    Hori YS; Nagakita K; Ebisudani Y; Aoi M; Fukuhara T; Shinno Y
    World Neurosurg; 2018 Jun; 114():230-234. PubMed ID: 29609086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S; Zafar MN; Best J; Reddy HK
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttransplant Lymphoproliferative Disorder in Kidney and Liver Transplant Recipients: A Single-Center Experience.
    Wójciak M; Gozdowska J; Dęborska-Materkowska D; Perkowska-Ptasińska A; Kosieradzki M; Nazarewski S; Durlik M
    Transplant Proc; 2018 Sep; 50(7):2154-2158. PubMed ID: 30177129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
    Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthracycline-based chemotherapy as first-line treatment in adults with malignant posttransplant lymphoproliferative disorder after solid organ transplantation.
    Taylor AL; Bowles KM; Callaghan CJ; Wimperis JZ; Grant JW; Marcus RE; Bradley JA
    Transplantation; 2006 Aug; 82(3):375-81. PubMed ID: 16906036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous Manifestations of Posttransplant Lymphoma in Renal Transplant Recipients: A Case Series.
    Patil R; Prashar R; Patel A
    Transplant Proc; 2021 Jun; 53(5):1519-1527. PubMed ID: 34134932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder.
    Rouphael B; Lankireddy S; Lazaryan A; Kukla A; Ibrahim HN; Matas AJ; Issa N
    Clin Transplant; 2016 Jan; 30(1):60-5. PubMed ID: 26497471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent posttransplant lymphoproliferative disorder involving the larynx and trachea: case report and review of the literature.
    Banks CA; Meier JD; Stallworth CR; White DR
    Ann Otol Rhinol Laryngol; 2012 May; 121(5):291-5. PubMed ID: 22724273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].
    Chen DB; Wang Y; Song QJ; Shen DH
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):607-12. PubMed ID: 23157829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous regression of central nervous system posttransplant lymphoproliferative disease: A case report.
    Gao R; Zhang Y; Chen G; Bhekharee AK; Du Z; Chu S
    Medicine (Baltimore); 2021 Feb; 100(6):e24713. PubMed ID: 33578612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.